Lpl Financial LLC Alkermes Plc. Transaction History

Lpl Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$23.21 - $27.24 $61,413 - $72,077	-2,646 Reduced 23.34%	8,691 $209,000
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $100,636 - $124,118	3,812 Added 50.66%	11,337 $306,000
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $5,234 - $6,424	224 Added 3.07%	7,525 $208,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $2,173 - $2,557	80 Added 1.11%	7,301 $204,000
Q2 2023 Jul 31, 2023	SELL	$28.34 - $33.63 $143,117 - $169,831	-5,050 Reduced 41.15%	7,221 $226,000
Q1 2023 May 10, 2023	BUY	$25.31 - $29.02 $74,082 - $84,941	2,927 Added 31.32%	12,271 $345,000
Q4 2022 Feb 07, 2023	BUY	$21.94 - $26.24 $205,007 - $245,186	9,344 New	9,344 $244,000
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $475,259 - $710,122	-22,136 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $517,318 - $711,229	22,136 New	22,136 $683,000
Q4 2018 Feb 07, 2019	SELL	$27.94 - $44.61 $139,616 - $222,916	-4,997 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $192,884 - $230,461	4,997 New	4,997 $212,000
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $297,832 - $377,136	-7,343 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $393,658 - $493,890	7,343 New	7,343 $426,000

364

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.61B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.